SUM Hospital seeks Third-stage COVID Vaccine Trial Patients

Bhubaneswar’s SUM Hospital has issued a fresh notice seeking to undertake around a thousand volunteers for the third phase clinical trials of Covaxin, an indigenous vaccine solution for the novel coronavirus being developed by the ICMR and BBIL. Those above eighteen years of age, and have never contracted the SARS-CoV-2 virus, are eligible for participation in the trial.

“We are targeting at least 1,000 volunteers preferable from Bhubaneswar, Cuttack and nearby areas for this trial as there are follow-up visits every month for seven months. Our objective is to let people from Odisha be benefited,” said Dr. E Venkata Rao, professor of the department of community medicine at SUM Hospital.

After the first two phases of the trial, which determined the safety aspect and explored immunology respectively, the third phase trial is targeted towards determining the efficacy of the vaccine. Chief Secretary Asit Tripathy informed that Odisha is now one step ahead in preparations for COVID vaccination in all parameters as per the national guideline. A multi-sectoral response system has been designed for smooth conduct of the vaccination program, whenever launched.

The vaccine will be given to citizens on a priority basis. The database for the priority group, comprising of frontline health workers from both government and private hospitals and workers under the ICDS scheme has been uploaded to the Co-Win web portal. An estimated 3.2 lakh have been put under high priority vaccination, National Health Mission (NHM) mission director Shalini Pandit informed.

Leave a comment